Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis

References

• Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236–237. doi:10.1001/jama.282.3.236
   PubMed Web of Science ®Google Scholar
• Krieger JN, Ross SO, Deutsch L, Riley DE. The NIH Consensus concept of chronic prostatitis/chronic pelvic pain syndrome compared with traditional concepts of nonbacterial prostatitis and prostatodynia. Curr Urol Rep. 2002;3(4):301–306. doi:10.1007/s11934-002-0054-z
   PubMedGoogle Scholar
• Schaeffer AJ. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med. 2006;355(16):1690–1698. doi:10.1056/NEJMcp060423
   PubMed Web of Science ®Google Scholar
• Motrich RD, Maccioni M, Riera CM, Rivero VE. Autoimmune prostatitis: state of the art. Scand J Immunol. 2007;66(2–3):217–227. doi:10.1111/j.1365-3083.2007.01971.x
   PubMed Web of Science ®Google Scholar
• Rivero VE, Iribarren P, Riera CM. Mast cells in accessory glands of experimentally induced prostatitis in male Wistar rats. Clin Immunol Immunopathol. 1995;74(3):236–242. doi:10.1006/clin.1995.1035
   PubMedGoogle Scholar
• Alexander RB, Brady F, Ponniah S. Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. Urology. 1997;50(6):893–899. doi:10.1016/S0090-4295(97)00456-1
   PubMed Web of Science ®Google Scholar
• Batstone GR, Doble A, Gaston JS. Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS). Clin Exp Immunol. 2002;128(2):302–307. doi:10.1046/j.1365-2249.2002.01853.x
   PubMed Web of Science ®Google Scholar
• Kouiavskaia DV, Southwood S, Berard CA, Klyushnenkova EN, Alexander RB. T-cell recognition of prostatic peptides in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2009;182(5):2483–2489. doi:10.1016/j.juro.2009.07.067
   PubMed Web of Science ®Google Scholar
• Motrich RD, Maccioni M, Molina R, et al. Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. Clin Immunol. 2005;116(2):149–157. doi:10.1016/j.clim.2005.03.011
   PubMed Web of Science ®Google Scholar
• Alexander RB, Ponniah S, Hasday J, Hebel JR. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology. 1998;52(5):744–749. doi:10.1016/S0090-4295(98)00390-2
   PubMed Web of Science ®Google Scholar
• Motrich RD, Maccioni M, Molina R, et al. Reduced semen quality in chronic prostatitis patients that have cellular autoimmune response to prostate antigens. Hum Reprod. 2005;20(9):2567–2572. doi:10.1093/humrep/dei073
   PubMed Web of Science ®Google Scholar
• Nadler RB, Koch AE, Calhoun EA, et al. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol. 2000;164(1):214–218. doi:10.1016/S0022-5347(05)67497-6
   PubMed Web of Science ®Google Scholar
• John H, John H, Barghorn A, et al. Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue. Eur Urol. 2001;39(1):72–78. doi:10.1159/000052415
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu Y, Chen X-G, et al. MicroRNA expression profile in chronic nonbacterial prostatitis revealed by next-generation small RNA sequencing. Asian J Androl. 2019;21(4):351–359. doi:10.4103/aja.aja_97_18
   PubMed Web of Science ®Google Scholar
• Breser ML, Motrich RD, Sanchez LR, Rivero VE. Chronic pelvic pain development and prostate inflammation in strains of mice with different susceptibility to experimental autoimmune prostatitis. Prostate. 2017;77(1):94–104. doi:10.1002/pros.23252
   PubMed Web of Science ®Google Scholar
• Du H, Chen X, Zhang L, et al. Experimental autoimmune prostatitis induces learning-memory impairment and structural neuroplastic changes in mice. Cell Mol Neurobiol. 2020;40(1):99–111. doi:10.1007/s10571-019-00723-2
   PubMed Web of Science ®Google Scholar
• Chen J, Zhan C, Zhang L, et al. The hypermethylation of foxp3 promoter impairs the function of treg cells in EAP. Inflammation. 2019;42(5):1705–1718. doi:10.1007/s10753-019-01030-0
   PubMed Web of Science ®Google Scholar
• Irani J, Levillain P, Goujon JM, Bon D, Doré B, Aubert J. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol. 1997;157(4):1301–1303. doi:10.1016/S0022-5347(01)64957-7
   PubMed Web of Science ®Google Scholar
• Trapnell C, Williams BA, Pertea G, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28(5):511–515. doi:10.1038/nbt.1621
   PubMed Web of Science ®Google Scholar
• Zhang SJ, Chen X, Li CP, et al. Identification and characterization of circular rnas as a new class of putative biomarkers in diabetes retinopathy. Invest Ophthalmol Vis Sci. 2017;58(14):6500–6509. doi:10.1167/iovs.17-22698
   PubMed Web of Science ®Google Scholar
• Elkahwaji JE, Hauke RJ, Brawner CM. Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. Br J Cancer. 2009;101(10):1740–1748. doi:10.1038/sj.bjc.6605370
   PubMed Web of Science ®Google Scholar
• Kramer G, Mitteregger D, Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol. 2007;51(5):1202–1216. doi:10.1016/j.eururo.2006.12.011
   PubMed Web of Science ®Google Scholar
• Nickel JC, True LD, Krieger JN, Berger RE, Boag AH, Young ID. Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int. 2001;87(9):797–805. doi:10.1046/j.1464-410x.2001.02193.x
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8
   PubMed Web of Science ®Google Scholar
• Moepps B, Frodl R, Rodewald HR, Baggiolini M, Gierschik P. Two murine homologues of the human chemokine receptor CXCR4 mediating stromal cell-derived factor 1alpha activation of Gi2 are differentially expressed in vivo. Eur J Immunol. 1997;27(8):2102–2112. doi:10.1002/eji.1830270839
   PubMed Web of Science ®Google Scholar
• Jazin EE, Soderstrom S, Ebendal T, Larhammar D. Embryonic expression of the mRNA for the rat homologue of the fusin/CXCR-4 HIV-1 co-receptor. J Neuroimmunol. 1997;79(2):148–154.
   PubMed Web of Science ®Google Scholar
• Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 1996;382(6594):833–835. doi:10.1038/382833a0
   PubMed Web of Science ®Google Scholar
• Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996;382(6594):829–833. doi:10.1038/382829a0
   PubMed Web of Science ®Google Scholar
• Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997;185(1):111–120. doi:10.1084/jem.185.1.111
   PubMed Web of Science ®Google Scholar
• Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184(3):1101–1109. doi:10.1084/jem.184.3.1101
   PubMed Web of Science ®Google Scholar
• Zhang M, Liu Y, Chen J, et al. Single-cell multi-omics analysis presents the landscape of peripheral blood T-cell subsets in human chronic prostatitis/chronic pelvic pain syndrome. J Cell Mol Med. 2020;24(23):14099–14109. doi:10.1111/jcmm.16021
   PubMed Web of Science ®Google Scholar
• Watanabe T, Inoue M, Sasaki K, et al. Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int. 2011;108(2):248–251. doi:10.1111/j.1464-410X.2010.09716.x
   PubMed Web of Science ®Google Scholar
• Nickel JC, Roehrborn CG, O’Leary MP, Bostwick DG, Somerville MC, Rittmaster RS. Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial. J Urol. 2007;178(3Pt 1):896–900; discussion 900–891. doi:10.1016/j.juro.2007.05.041
   Web of Science ®Google Scholar
• Breser ML, Salazar FC, Rivero VE, Motrich RD. Immunological mechanisms underlying chronic pelvic pain and prostate inflammation in chronic pelvic pain syndrome. Front Immunol. 2017;8:898. doi:10.3389/fimmu.2017.00898
   PubMedGoogle Scholar
• Marques RE, Marques PE, Guabiraba R, Teixeira MM. Exploring the homeostatic and sensory roles of the immune system. Front Immunol. 2016;7:125. doi:10.3389/fimmu.2016.00125
   PubMed Web of Science ®Google Scholar
• Sanchez-Martin L, Estecha A, Samaniego R, Sanchez-Ramon S, Vega MA, Sanchez-Mateos P. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood. 2011;117(1):88–97. doi:10.1182/blood-2009-12-258186
   PubMed Web of Science ®Google Scholar
• Bhangoo SK, Ren D, Miller RJ, et al. CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav Immun. 2007;21(5):581–591. doi:10.1016/j.bbi.2006.12.003
   PubMed Web of Science ®Google Scholar
• Bai L, Wang X, Li Z, et al. Upregulation of chemokine CXCL12 in the dorsal root ganglia and spinal cord contributes to the development and maintenance of neuropathic pain following spared nerve injury in rats. Neurosci Bull. 2016;32(1):27–40. doi:10.1007/s12264-015-0007-4
   PubMed Web of Science ®Google Scholar
• Saha A, Ahn S, Blando J, Su F, Kolonin MG, DiGiovanni J. Proinflammatory CXCL12-CXCR4/CXCR7 signaling axis drives myc-induced prostate cancer in obese mice. Cancer Res. 2017;77(18):5158–5168. doi:10.1158/0008-5472.CAN-17-0284
   PubMed Web of Science ®Google Scholar
• García-Cuesta EM, Santiago CA, Vallejo-Díaz J, Juarranz Y, Rodríguez-Frade JM, Mellado M. The role of the CXCL12/CXCR4/ACKR3 axis in autoimmune diseases. Front Endocrinol (Lausanne). 2019;10:585. doi:10.3389/fendo.2019.00585
   PubMed Web of Science ®Google Scholar
• Zgraggen S, Huggenberger R, Kerl K, Detmar M. An important role of the SDF-1/CXCR4 axis in chronic skin inflammation. PLoS One. 2014;9(4):e93665. doi:10.1371/journal.pone.0093665
   PubMed Web of Science ®Google Scholar
• Kohler RE, Comerford I, Townley S, Haylock-Jacobs S, Clark-Lewis I, McColl SR. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Brain Pathol. 2008;18(4):504–516. doi:10.1111/j.1750-3639.2008.00154.x
   PubMed Web of Science ®Google Scholar
• Agace WW, Amara A, Roberts AI, et al. Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr Biol. 2000;10(6):325–328. doi:10.1016/S0960-9822(00)00380-8
   PubMed Web of Science ®Google Scholar
• Dotan I, Werner L, Vigodman S, et al. CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system. Inflamm Bowel Dis. 2010;16(4):583–592. doi:10.1002/ibd.21106
   PubMed Web of Science ®Google Scholar
• Werner L, Elad H, Brazowski E, et al. Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease. J Leukoc Biol. 2011;90(3):583–590. doi:10.1189/jlb.0111101
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu S, He C, et al. CXCL12-CXCR4-mediated chemotaxis supports accumulation of mucosal-associated invariant T cells into the liver of patients with PBC. Front Immunol. 2021;12:578548. doi:10.3389/fimmu.2021.578548
   PubMed Web of Science ®Google Scholar
• Jia YL, Liu X, Yan JY, et al. The alteration of inflammatory markers and apoptosis on chronic prostatitis induced by estrogen and androgen. Int Urol Nephrol. 2015;47(1):39–46. doi:10.1007/s11255-014-0845-4
   PubMed Web of Science ®Google Scholar
• Jeon SH, Zhu GQ, Kwon EB, et al. Extracorporeal shock wave therapy decreases COX-2 by inhibiting TLR4-NFkappaB pathway in a prostatitis rat model. Prostate. 2019;79(13):1498–1504. doi:10.1002/pros.23880
   PubMed Web of Science ®Google Scholar
• Murphy SF, Schaeffer AJ, Done J, et al. IL17 mediates pelvic pain in experimental autoimmune prostatitis (EAP). PLoS One. 2015;10(5):e0125623. doi:10.1371/journal.pone.0125623
   PubMed Web of Science ®Google Scholar
• Altuntas CZ, Daneshgari F, Veizi E, et al. A novel murine model of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by immunization with a spermine binding protein (p25) peptide. Am J Physiol Regul Integr Comp Physiol. 2013;304(6):R415–422. doi:10.1152/ajpregu.00147.2012
   PubMed Web of Science ®Google Scholar
• Lu JC, Shen JM, Hu XC, Peng LP, Hong ZW, Yao B. Identification and preliminary study of immunogens involved in autoimmune prostatitis in human males. Prostate. 2018;78:1092–1102. doi:10.1002/pros.23684
   Web of Science ®Google Scholar